Punch & Associates Investment Management’s Immunomedics Inc IMMU Stock Holding History

Punch & Associates Investment Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,080	Closed	-$432K	–	254
2020 Q3	$432K	Buy	+5,080	New	+$257K	0.04%	195

Punch & Associates Investment Management's IMMU Position: Q4 2020 in Review

Punch & Associates Investment Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 5,080 shares — an estimated $432K sold.

Punch & Associates Investment Management first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $432K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Punch & Associates Investment Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Punch & Associates Investment Management sold 5,080 Immunomedics Inc shares in Q4 2020, an estimated $432K.
Punch & Associates Investment Management first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
Punch & Associates Investment Management's Immunomedics Inc position peaked at $432K in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Punch & Associates Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.